Metraipolis › archive › dc_cded4ee29b35

Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC — Europe PMC PMID:42643285

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42643285
DOI
10.3389/fimmu.2026.1852284
License (as archived)
solo-consultazione
Archived
2026-10-16T21:43:20.357Z
SHA-256 of the archived text
aac6abc6bfc366431ec46d892186a44d007644f734f86224b940ee6438d56523
Stable URL of this page
https://metraipolis.com/documento/dc_cded4ee29b35

How to cite

Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC — Europe PMC PMID:42643285 — Europe PMC (en), https://europepmc.org/article/MED/42643285 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cded4ee29b35 (Metraipolis archive dc_cded4ee29b35, sha256 aac6abc6bfc366431ec46d892186a44d007644f734f86224b940ee6438d56523)
BibTeX
@misc{dccded4ee29b35,
  title = {Intratumoral heterogeneity as a potential biomarker for immunotherapy response and postoperative recurrence in NSCLC — Europe PMC PMID:42643285},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42643285},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cded4ee29b35; sha256 aac6abc6bfc366431ec46d892186a44d007644f734f86224b940ee6438d56523},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42643285. Agents can read the archived copy with the MCP tool read_document.